> top > docs > PMC:7556165 > spans > 72053-72259 > annotations

PMC:7556165 / 72053-72259 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T405 59-69 Species denotes SARS-CoV-2 NCBItxid:2697049
T406 59-63 Species denotes SARS NCBItxid:694009

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T425 0-206 Sentence denotes Remarkably, combinatorial mutants enhanced ACE2 binding to SARS-CoV-2 RBD by an order of magnitude, as compared to the wild type receptor form, and targeted ACE2 mutations might provide further improvement.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
1962 43-47 Gene denotes ACE2 Gene:59272
1963 157-161 Gene denotes ACE2 Gene:59272
1970 59-69 Species denotes SARS-CoV-2 Tax:2697049

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T6243 43-47 Protein denotes ACE2 https://www.uniprot.org/uniprot/Q9UFZ6
T6244 70-73 Protein denotes RBD https://www.uniprot.org/uniprot/Q63492|https://www.uniprot.org/uniprot/Q63491|https://www.uniprot.org/uniprot/Q62815|https://www.uniprot.org/uniprot/Q62691|https://www.uniprot.org/uniprot/Q01542|https://www.uniprot.org/uniprot/P27732|https://www.uniprot.org/uniprot/O09024|https://www.uniprot.org/uniprot/O09023|https://www.uniprot.org/uniprot/O09022
T6253 157-161 Protein denotes ACE2 https://www.uniprot.org/uniprot/Q9UFZ6

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T427 59-69 Disease denotes SARS-CoV-2 http://purl.obolibrary.org/obo/MONDO_0100096
T428 59-63 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1962 43-47 Gene denotes ACE2 Gene:59272
1963 157-161 Gene denotes ACE2 Gene:59272
1970 59-69 Species denotes SARS-CoV-2 Tax:2697049

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T425 0-206 Sentence denotes Remarkably, combinatorial mutants enhanced ACE2 binding to SARS-CoV-2 RBD by an order of magnitude, as compared to the wild type receptor form, and targeted ACE2 mutations might provide further improvement.